I have some confusion about the SDTM version submission to FDA. For now, the latest version of SDTM is v1.4 and IG is 3.2( with AP v1.0 and MD v1.0). However, FDA, so far, only accept SDTM v1.3 (IG 3.1.3). Since we don't have the date for acceptancy of SDTM v1.4, then on what reason we can still use the SDTM v1.4?
Or new domains in the SDTM v1.4 can be treated as custom domain when submitted to FDA? What about AP-- domain, or new variables ?
Pinnacle 21 uses cookies to make our site easier for you to use. By continuing to use this website, you agree to our use of cookies. For more info visit our Privacy Policy.
Hi,
I have some confusion about the SDTM version submission to FDA. For now, the latest version of SDTM is v1.4 and IG is 3.2( with AP v1.0 and MD v1.0). However, FDA, so far, only accept SDTM v1.3 (IG 3.1.3). Since we don't have the date for acceptancy of SDTM v1.4, then on what reason we can still use the SDTM v1.4?
Or new domains in the SDTM v1.4 can be treated as custom domain when submitted to FDA? What about AP-- domain, or new variables ?
Thanks in advanced!